title: Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention.
authors.affiliation: Burnet Institute, Centre for Population Health, Melbourne, Victoria, Australia. pauld@burnet.edu.au.|School of Public Health and Preventive Medicine, Melbourne, Victoria, Australia. pauld@burnet.edu.au.
authors.forename: Paul
authors.initials: P
authors.lastname: Dietze
authors.affiliation: Burnet Institute, Centre for Population Health, Melbourne, Victoria, Australia.|School of Public Health and Preventive Medicine, Melbourne, Victoria, Australia.
authors.forename: Kate
authors.initials: K
authors.lastname: Cantwell
mesh_terms: D000281:Administration, Intranasal; D062787:Drug Overdose / Q000150:complications / Q000517:prevention & control*; D006291:Health Policy / Q000331:legislation & jurisprudence; D006801:Humans; D009270:Naloxone / Q000008:administration & dosage*; D009292:Narcotic Antagonists / Q000008:administration & dosage*; D009293:Opioid-Related Disorders / Q000150:complications*; D010818:Practice Patterns, Physicians'; D012648:Self Care / Q000379:methods
chemical_list: D009292:Narcotic Antagonists; D009270:Naloxone
keywords: Naloxone; intranasal; opioid overdose; overdose response; resuscitation; take-home naloxone